Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma

被引:2
|
作者
Rameh, V. [1 ]
Vajapeyam, S. [1 ]
Ziaei, A. [1 ]
Kao, P. [2 ]
London, W. B. [2 ]
Baker, S. J. [3 ]
Chiang, J. [4 ,5 ]
Lucas, J.
Tinkle, C. L. [5 ]
Wright, K. D. [2 ]
Poussaint, T. Y. [1 ,6 ]
机构
[1] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Boston, MA USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[3] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN USA
[4] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
[5] St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN USA
[6] Boston Childrens Hosp, Dept Radiol, 300 Longwood Ave, Boston, MA 02115 USA
关键词
DIFFUSE MIDLINE GLIOMAS; CENTRAL-NERVOUS-SYSTEM; APPARENT DIFFUSION; TUMORS; SURVIVAL; FEATURES; CLASSIFICATION; MUTATIONS; SUBGROUPS; BIOPSY;
D O I
10.3174/ajnr.A7910
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Molecular profiling is a crucial feature in the "integrated diagnosis" of CNS tumors. We aimed to determine whether radiomics could distinguish molecular types of pontine pediatric high-grade gliomas that have similar/overlapping phenotypes on conventional anatomic MR images.MATERIALS AND METHODS: Baseline MR images from children with pontine pediatric high-grade gliomas were analyzed. Retrospective imaging studies included standard precontrast and postcontrast sequences and DTI. Imaging analyses included median, mean, mode, skewness, and kurtosis of the ADC histogram of the tumor volume based on T2 FLAIR and enhancement at baseline. Histone H3 mutations were identified through immunohistochemistry and/or Sanger or next-generation DNA sequencing. The log-rank test identified imaging factors prognostic of survival from the time of diagnosis. Wilcoxon rank-sum and Fisher exact tests compared imaging predictors among groups.RESULTS: Eighty-three patients had pretreatment MR imaging and evaluable tissue sampling. The median age was 6 years (range, 0.7-17 years); 50 tumors had a K27M mutation in H3-3A, and 11, in H3C2/3. Seven tumors had histone H3 K27 alteration, but the specific gene was unknown. Fifteen were H3 wild-type. Overall survival was significantly higher in H3C2/3-compared with H3-3A -mutant tumors (P = .003) and in wild-type tumors compared with any histone mutation (P = .001). Lower overall survival was observed in patients with enhancing tumors (P = .02) compared with those without enhancement. H3C2/3-mutant tumors showed higher mean, median, and mode ADC_total values (P<.001) and ADC_enhancement (P<.004), with lower ADC_total skewness and kurtosis (P<.003) relative to H3-3A-mutant tumors. CONCLUSIONS: ADC histogram parameters are correlated with histone H3 mutation status in pontine pediatric high-grade glioma.
引用
收藏
页码:833 / 840
页数:8
相关论文
共 50 条
  • [31] Reoperation for Recurrent High-Grade Glioma: Does Tumor Genetics Play a Role?
    Zhao, Xin
    Bai, Harrison X.
    Zou, Yingjie
    Yang, Li
    NEUROSURGERY, 2015, 76 (04) : E496 - E497
  • [32] Pediatric high-grade glioma: biologically and clinically in need of new thinking
    Jones, Chris
    Karajannis, Matthias A.
    Jones, David T. W.
    Kieran, Mark W.
    Monje, Michelle
    Baker, Suzanne J.
    Becher, Oren J.
    Cho, Yoon-Jae
    Gupta, Nalin
    Hawkins, Cynthia
    Hargrave, Darren
    Haas-Kogan, Daphne A.
    Jabado, Nada
    Li, Xiao-Nan
    Mueller, Sabine
    Nicolaides, Theo
    Packer, Roger J.
    Persson, Anders I.
    Phillips, Joanna J.
    Simonds, Erin F.
    Stafford, James M.
    Tang, Yujie
    Pfister, Stefan M.
    Weiss, William A.
    NEURO-ONCOLOGY, 2017, 19 (02) : 153 - 161
  • [33] Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread
    Marinari, Eliana
    Dutoit, Valerie
    Nikolaev, Sergey
    Vargas, Maria-Isabel
    Schaller, Karl
    Lobrinus, Johannes Alexander
    Dietrich, Pierre-Yves
    Tsantoulis, Petros
    Migliorini, Denis
    NEUROLOGY-GENETICS, 2021, 7 (02) : e561
  • [34] HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade Glioma
    Sasame, Jo
    Ikegaya, Naoki
    Kawazu, Masahito
    Natsumeda, Manabu
    Hayashi, Takahiro
    Isoda, Masataka
    Satomi, Kaishi
    Tomiyama, Arata
    Oshima, Akito
    Honma, Hirokuni
    Miyake, Yohei
    Takabayashi, Katsuhiro
    Nakamura, Taishi
    Ueno, Toshihide
    Matsushita, Yuko
    Iwashita, Hiromichi
    Kanemaru, Yu
    Murata, Hidetoshi
    Ryo, Akihide
    Terashima, Keita
    Yamanaka, Shoji
    Fujii, Yukihiko
    Mano, Hiroyuki
    Komori, Takashi
    Ichimura, Koichi
    Cahill, Daniel P.
    Wakimoto, Hiroaki
    Yamamoto, Tetsuya
    Tateishi, Kensuke
    CLINICAL CANCER RESEARCH, 2022, 28 (11) : 2425 - 2439
  • [35] Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases
    Mouthuy, Nathalie
    Cosnard, Guy
    Abarca-Quinones, Jorge
    Michoux, Nicolas
    JOURNAL OF NEURORADIOLOGY, 2012, 39 (05) : 301 - 307
  • [36] Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial
    McCrea, Heather J.
    Ivanidze, Jana
    O'Connor, Ashley
    Hersh, Eliza H.
    Boockvar, John A.
    Gobin, Y. Pierre
    Knopman, Jared
    Greenfield, Jeffrey P.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2021, 28 (04) : 371 - 379
  • [37] Pediatric Non-Brain Stem High-Grade Glioma: A Single-Center Experience
    Alimohammadi, Ehsan
    Bagheri, Seyed Reza
    Delfani, Nasrin
    Safari-Faramani, Roya
    Janatolmakan, Maryam
    INDIAN JOURNAL OF NEUROSURGERY, 2020, 9 (03) : 162 - 169
  • [38] Conventional and advanced magnetic resonance imaging in patients with high-grade glioma
    Pope, Whitney B.
    Brandal, Garth
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 62 (03) : 239 - 253
  • [39] WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
    Varlet, Pascale
    Le Teuff, Gwenael
    Le Deley, Marie-Cecile
    Giangaspero, Felice
    Haberler, Christine
    Jacques, Thomas S.
    Figarella-Branger, Dominique
    Pietsch, Torsten
    Andreiuolo, Felipe
    Deroulers, Christophe
    Jaspan, Tim
    Jones, Chris
    Grill, Jacques
    NEURO-ONCOLOGY, 2020, 22 (01) : 116 - 127
  • [40] Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series
    Buccoliero, Anna Maria
    Giunti, Laura
    Moscardi, Selene
    Castiglione, Francesca
    Provenzano, Aldesia
    Sardi, Iacopo
    Scagnet, Mirko
    Genitori, Lorenzo
    Caporalini, Chiara
    GENES, 2022, 13 (04)